Status:
COMPLETED
Adherence, Efficacy and Safety of an Insulin Protocol in the Critically Ill: A Prospective Observational Study
Lead Sponsor:
University Hospital, Ghent
Conditions:
Critically Ill Patients
Eligibility:
All Genders
16+ years
Phase:
PHASE2
Brief Summary
There is a growing body of evidence in the literature regarding the adverse effects of hyperglycemia in critically ill patients. To target and maintain better blood glucose regulation we implemented a...
Eligibility Criteria
Inclusion
- Surgical or medical critically ill patients
- An expected ICU-stay of more than 72 hours
- Age \> 16 years
- Need for insulin therapy
- Patients must have an arterial line
Exclusion
- Patients who did not respond to the inclusion criteria
- Patients with diabetic ketoacidosis
- Cardiac surgical patients
- Patients transferred from other hospitals
- Other study enrollment
Key Trial Info
Start Date :
September 1 2002
Trial Type :
INTERVENTIONAL
End Date :
December 1 2002
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00288743
Start Date
September 1 2002
End Date
December 1 2002
Last Update
December 28 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Ghent
Ghent, Belgium, 9000